PT  - JOURNAL ARTICLE
AU  - Brum, Arthur A.
AU  - Vasconcelos, Giovani L.
AU  - Duarte-Filho, Gerson C.
AU  - Ospina, Raydonal
AU  - Almeida, Francisco A. G.
AU  - Macêdo, Antônio M. S.
TI  - ModInterv COVID-19: An online platform to monitor the evolution of epidemic curves
AID  - 10.1101/2022.01.31.22270192
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.31.22270192
4099  - http://medrxiv.org/content/early/2022/06/06/2022.01.31.22270192.short
4100  - http://medrxiv.org/content/early/2022/06/06/2022.01.31.22270192.full
AB  - We present the software ModInterv as an informatics tool to monitor, in an automated and user-friendly manner, the evolution and trend of COVID-19 epidemic curves, both for cases and deaths. The ModInterv software uses parametric generalized growth models, together with LOWESS regression analysis, to fit epidemic curves with multiple waves of infections for countries around the world as well as for states and cities in Brazil and the USA. The software automatically accesses publicly available COVID-19 databases maintained by the Johns Hopkins University (for countries as well as states and cities in the USA) and the Federal University of Viçosa (for states and cities in Brazil). The richness of the implemented models lies in the possibility of quantitatively and reliably detecting the distinct acceleration regimes of the disease. We describe the backend structure of software as well as its practical use. The software helps the user not only to understand the current stage of the epidemic in a chosen location but also to make short term predictions as to how the curves may evolve. The app is freely available on the internet (http://fisica.ufpr.br/modinterv), thus making a sophisticated mathematical analysis of epidemic data readily accessible to any interested user.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge partial financial support from CNPq and CAPES Brazil.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJohns Hopkins University https://coronavirus.jhu.edu/map.html and GitHub database maintained by Wesley Cota https://github.com/wcota/covid19br